These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs. Schito GC; Pesce A; Debbia EA Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761 [TBL] [Abstract][Full Text] [Related]
69. Clinical advances in oral antibiotic therapy. Summary and closing remarks. Neu HC Postgrad Med J; 1979; 55 Suppl 4():100-1. PubMed ID: 548938 [No Abstract] [Full Text] [Related]
70. Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe. Preston DA; Turik M J Chemother; 1998 Jun; 10(3):195-202. PubMed ID: 9669643 [TBL] [Abstract][Full Text] [Related]
77. In vitro antibacterial activity of cefixime. Lin SR; Peng CF Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Oct; 4(10):586-91. PubMed ID: 3230604 [No Abstract] [Full Text] [Related]
78. Treatment of otitis media with cefaclor, a new oral cephalosporin. Aronovitz GH South Med J; 1980 Nov; 73(11):1447-9. PubMed ID: 6969442 [TBL] [Abstract][Full Text] [Related]
79. A pharmacological and in vitro comparison of three oral cephalosporins. Wise R; Andrews JM; Dean S; Welling PG; Kendall MJ J Antimicrob Chemother; 1979 Sep; 5(5):601-7. PubMed ID: 115833 [TBL] [Abstract][Full Text] [Related]
80. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria. Nord CE; Lindmark A; Persson I Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]